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Summary 
This study presents a retrospective review of the outcome of familial adenomatous 
polyposis treated at an academic hospital, but in the absence of a formal Polyposis 
Registry. 
Familial adenomatous polyposis is a disease which is inherited in an autosomal 
dominant pattern. It causes large bowel adenomas at a mean age of 16 years, 
symptoms at a mean of 24 years and death from large bowel cancer at, on average 
42 years. Its easily recognisable mode of inheritance, and the possibility of 
preventing colon cancer by colectomy, have led to the early diagnosis of family 
members, to prophylactic surgery, and to the establishment of Polyposis Registries 
to facilitate this. 
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Introduction 
The St Mark's Polyposis Registry was the first Polyposis Registry to be established. 
It originated from three families identified and studied by Lockhart-Mummery in 
19251. From then the St. Marks Pol yposis Registry has grown to be the largest 
register of intestinal polyps in the world and more than 200 families were registered 
by 1975.2 
Registries have been established 111 many countries including Denmark3, Japan4, 
The Netherlands5, United Kingdom2 and Western Australia 6. It has generally been 
assumed that these Registries have been effective in reducing deaths from colorectal 
cancer in familial adenomatous polyposis. This question however has never been 
studied systematically . 
In 1964 the first patient with familial adenomatous polyposis was identified at 
Groote Schuur Hospital and investigation of this family 7 became the subject of the 
first South African publication on this condition. 
A polyposis registry is designed to identify family members of patients at risk of 
developing the disease and arrange their screening. In addition it ensures optimum 
follow up of patients proven to have familial adenomatous polyposis. Registries 
also provide most of the available data concerning familial adenomatous polyposis. 
It is likely, however, that the majority of patients world wide with familial 
adenomatous polyposis are managed without access to such a registry. 
A registry is expensive. In order to justify its cost it must provide major benefits. 
The majority of patients who develop large bowel cancer in association with familial 
adenomatous polyposis do so at an age when they are economically active. The 
registry may justify its existence economically if it reduces the incidence of cancer 
of the large bowel at diagnosis and increases the longevity of these patients. 
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There is no polyposis registry in South Africa. The patients seen at Groote Schuur 
Hospital thus illustrate the course of the disease in patients who do not have access 
to a registry. Their outcome may perhaps merit comparison with that of patients 
managed through a registry , although no data which allow a valid comparison have 
been published to date. Hence this study does not try to answer the question of 
whether a Polyposis Registry is cost effective, but merely documents the outcome of 
the disease in our patients. This study is unusual in providing data on a relatively 
large number of cases treated in the absence of a formal registry. 
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Historical Review 
The first report of multiple polyps of the colon is usually ascribed to Menzel8 who 
in 1721 probably described inflammatory polyposis. Adenomatous polyposis may 
have been recorded by Corvisart9 in 1847 and 12 years later Chargelaigue10 
probably gave the first account of the disease in a 16 year old girl and a 21 year old 
man. Woodward 11 differentiated adenomatous polyps which he called primary 
from inflammatory or secondary polyps. The development of microscopy and with 
it histology allowed the differentiation of polyps and the separation of hyperplastic 
and neoplastic from inflammatory ones. Cripps 12 first recorded the familial nature 
of adenomatous polyps in a brother and a sister. By 1900 the familial nature was 
well established. 13-15 The association between cancer and familial polyps was 
probably mentioned first by Handford 16_ 
With the passage of time, familial polyps have become increasing defined. Peutz17 
in 1921 and Jeghers l 8 in 1949 separated hamartomatous polyps from the familial 
adenomatous grouping. Though early reports of this condition associated it with a 
high incidence of cancer, it was later shown that this was not correct and was 
probably due to mistaken interpretation of the pathology.19-21 
In 1966 Veale22 recognised that adenomatous polyps rarely occurred in patients 
under 10 years. The condition of multiple juvenile polyps (mucous retention 
polyps) was identified. This stressed the importance of histological confirmation in 
all cases of polyposis. 
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The first Registry to be established was that at St Mark's hospital in 1925 around 
three families reported by JP Lockhart-Mummery1. All forms of polyposis of the 
gastrointestinal tract were included .2 This registry remains a loco-regional one and 
is not a national registry but by 1989 it maintained records of nearly 1000 
patients. 23 It is estimated that this registry contains information on only between 
one tenth to one third of all British polyposis families. 2 
A number of other local registries exist within the United Kingdom23 and 
Australia. 6 
National registries have been completed in Denmark3 and Sweden24 and are being 
developed in Norway and Japan . The Danish register is probably complete as 
between 1977 and 1979 only two new families were identified and between 1979 
and 1984 there were no new families diagnosed. 3 
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Patholoeical abnormalities in familial adenomatous polyposis 
The condition was originally labeled familial polyposis coli because it was thought 
to be limited to the colon and rectum. It has however become evident that virtually 
all patients develop upper gastrointestinal adenomas and the generally accepted 
name for the condition has thus changed to familial adenomatous polyposis. In the 
early 1950's Gardner and his colleagues described a condition associated with 
familial adenomatous polyposis involving all three germ layers. 25-28 Some lesions 
are associated with morbidity and mortality while others are markers of patients 
who have yet to express the phenotype. 29 
A) Abnormalities of endodermal origin 
1. Colorectal polyps 
Though the mean age of development of polyps is 16 years30 the range is at least 
from eighteen months to 34 years of age. Affected individuals usually have at least 
1000 adenomas but this may depend on the age of the patient at the time of removal 
of the colon. There are reports of rectal sparing and sigmoidoscopic examination 
alone will miss these individuals. 31 
2. Gastric polyps 
Fundic polyps are usually mucous retention hamartomas with little malignant 
potential. 32 10 % of patients have gastric adenomas33 and a few cases of gastric 
carcinoma have been reported. 34-36 
3. Duodenal / periampullary polyps 
Duodenal polyps may be found in up to 94 % of patients with familial adenomatous 
polyposis. 3? They are most numerous in the second and third parts of the 
duodenum especially in the periampullary region. Duodenal and periampullary 
carcinoma appears to be more common than originally thought, and may be the 
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f d h . . h . 1 tal al" 38 39 most common cause o eat m patients w o survive co orec m 1gnancy. ' 
Bile may be a co-carcinogen in this condition. 4o 
4. Small bowel polyps 
Adenomas may occur both m the jejunum and ileum. The risk of malignancy 
appears smalt.41 ,42 
5. Gall bladder, Bile duct. pancreas and pancreatic duct 
There appears to be an increased frequency of hepato-billary and pancreatic 
adenomas and carcinomas.43,44 
6. Thyroid carcinoma 
Females under 35 years have a l 60X greater incidence of papillary carcinoma if 
they have familial adenomatous polyposis. 45 
7. Other endocrine tumours 
Adrenal carcinomas, multiple endocrine neoplasia type 2b, pituitary adenomas and 
pancreatic islet tumours have all been reported. 46-50 
B) Abnormalities mesoderm ori~in 
1. Skeletal abnormalities 
Occult osteomata may occur in up to 90% of patients with familial adenomatous 
pol yposis . 51 
2. Dental Abnormalities 
These form part of the original description of Gardner's syndrome 26,27 and 
include early caries with tooth loss, supernumerary teeth , odontomas, dentigerous 
cysts and impacted permanent teeth. 
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3. Hepatoblastoma 
There is a higher than expected incidence of hepatoblastomas in the offspring of 
patients with familial adenomatous polyposis. 52 
4. Desmoids 
Two types of desmoids occur m about 10% of familial adenomatous polyposis 
patients. 2 The intra-abdominal type are either mesenteric of retroperitoneal 
vascular tumours, whereas the muscular-aponeurotic type are more fibrotic and tend 
to occur in scars. Growth rate is variable and may possibly be stimulated by 
pregnancy or surgery. 53 The intra-abdominal variety is difficult to remove totally, 
has a high recurrence rate and may bleed uncontrollably during surgery. 54 There 
appears to be a high incidence of post operative intestinal obstruction which may be 
related to a disorder of fibrous tissue formation. 55 
C) Abnormalities of ectodermal ori~in 
1. Cutaneous lesions 
Epidermoid and sebaceous cysts form part of the original description by 
Gardner. 25-27 
2. Central nervous system tumours 
Astrocytoma and medulloblastoma occur in Turcot' s syndrome56 
3. Congenital hypertrophy of the retinal pigment epithelium.(CHRPE) 
These discrete pigmented lesions are multiple and bilateral in patients with familial 
adenomatous polyposis but they may be absent. They serve as a marker of the gene 
when present.(see below) 
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The present study 
Method 
Between 1964 and 1974, at Groote Schuur Hospital, a social worker and a part-time 
consultant surgeon followed up patients with familial adenomatous polyposis and 
screened their families. This service lapsed between 1974 and 1988, when a 
systematic screening service was again instituted. In January 1988, a research nurse 
was employed to trace all patients with familial adenomatous polyposis treated at 
Groote Schuur Hospital to establish their outcome. 
During 1988 the hospital records were searched for all patients who had been seen 
at Groote Schuur Hospital and a diagnosis of familial adenomatous polyposis made. 
These records were reviewed as were those of the Department of Pathology. The 
private records of a number of surgeons were compared with the list of names 
obtained from the above sources. Additional patient names were identified from the 
raw data collected for the article by Aitken et al. 57 
Once the names of all patients treated at Groote Schuur Hospital had been collected 
their hospital folders were searched and the information about the course of the 
disease in the individual patients collected on a pro-forma (appendix). 
The genealogical records of Dr Marie Torrington (the social worker mentioned 
above) who had traced patients at Groote Schuur Hospital from 1964 to 1974, of the 
Medical Research ·council were reviewed to identify family members of patients 
seen at Groote Schuur Hospital who were at risk of developing the disease. 
Attempts were made to trace these family members. Those that could be contacted 
were called up for screening . 
Familial adenomatous polyposis was diagnosed if several adenomas were proven in 
patients with more than 100 polyps in the large bowel. More than one polyp was 
always biopsied for proof of adenoma. 
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The chi-squared test with Yates' correction was used to compare proportions for 
large samples and Fisher's exact test for small samples. Normally distributed data 
were compared by Student's t-test. Variables not normally distributed were 
compared using Wilcoxon' s signed rank test. 
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Results 
During the 26 years 70 patients with familial adenomatous polyposis were seen. The 
number of patients diagnosed per year is demonstrated graphically in figure I, with 
the age at diagnosis in figure II. Figure III shows the race and sex distribution. 
Symptoms vs stage of disease 
Two patients had no family history of familial adenomatous polyposis and in seven 
the family history was unknown. The remaining 61 patients were from 8 families 
(Figure IV). In patients for whom information on symptoms at presentation was 
available, half were symptomatic, had a higher prevalence of large bowel cancer at 
diagnosis and were on average IO years older than the asymptomatic patients (Table 
I). 
Operations: Short-term results 
In all, 99 operations were performed in 67 patients (1.5 operations/patient) (Figure 
V). A further three patients have refused both surgical management and follow up, 
of whom two are lost, while another died 6 years after diagnosis aged 55 years of 
colon cancer. The most common operation performed to prevent large bowel 
cancer was a colectomy and ilea-rectal anastomosis in 58 patients, one of whom had 
a prior colostomy for an obstructing carcinoma of the descending colon. Of these 
patients 15 (26%) have subsequently had at least one other operation for familial 
adenomatous polyposis, excluding fulguration of rectal polyps, during a median 
follow up of IO years . Two of these patients and two unoperated cases underwent 
ileo-anal pouch procedures. Table II contrasts the complications which followed 
colectomy and ileo-rectal anastomosis and ileo-anal pouch procedures. Two of 58 
patients (3 % ) have undergone revision of colectomy and ilea-rectal anastomosis to 
proctocolectomy with ileostomy, 1 for rectal cancer after 12 years and the other for 
multiple large polyps with severe dysplasia 10 years after colectomy and ilea-rectal 
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anastomosis. Two of four patients have had their ileal pouch removed for 
incontinence for which no organic cause could be found. 
Long-term results 
Histological material from the first operation could be reviewed in the 59 of the 67 
operated patients. Fifty-one had adenomas. The remaining eight (16%) had cancer 
and the stage at diagnosis was Dukes A in two, C in four and two had residual intra 
abdominal disease at operation with an overall 5 year survival of 50% .(Table VI) 
Reliable data on examination of the retained rectum after colectomy and ilea-rectal 
anastomosis was available for 22 patients. Only nine ( 40 % ) had undergone 
sigmoidoscopy at least once a year. Figure VII shows the incidence of carcinoma of 
the rectal remnant after colectomy and ilea-rectal anastomosis. The duration of 
follow up of all 70 patients is shown in figure VIII. Nine have been lost to follow 
up after 1, 1, 10, 10, 10, 12, 21, 23 and 24 years (mean 11 years), while of the 
remainder 14 have died. The cause of death is unknown in five patients and one 
died of ischaemic heart disease. The remaining eight patients (57 % ) died as a result 
of familial adenomatous polyposis: six of carcinoma of the large bowel (present at 
diagnosis in five), one patient of cancer of the duodenum and another of a desmoid 
causing perforation of the small bowel. In 18 patients, gastroscopy with an end-
viewing instrument identified adenomatous polyps in four, of whom one had an 
antrectomy. Five patients have had retention polyps. No duodenal polyps were 
found. 
Since a systematic screening programme was resumed in 1988 the median age at 
diagnosis has fallen, and the number of new cases identified annually has risen as 
has the proportion without symptoms or cancer (Table III). 
The outcome of all 70 patients is summarised in table IV. 
Table I: symptoms at presentation vs age 
Symptomatic 
Asymptomatic 
Unknown 
Total 
p = 0.0005 
p = 0.02 
p = 0.04 
Number Mean age Large bowel cancer 
(years) at diagnosis 
30 34 7 
30 24 1 
10 24 0 
70 
age, symptomatic vs asymptomatic. 
age, symptomatic vs unknown. 
proportion with cancer at diagnosis. 
16 
Table II: Complications after total colectomy and ileo-
rectal anastomosis (n = 58) and ileal pouch (n = 4) 
Complication IRA Pouch 
Anastomotic leak (no stoma) 1 
Wound dehiscence 1 
Wound infection 4 
Small bowel obstruction 4 
(within 30 days) 
Death 0 0 
Deep vein thrombosis 1 
Intra-abdominal sepsis 1 
Eventual permanent ileostomy * 2 2 
* p = 0.02 
17 
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Table III 
Screening Programme 
Before After 
(1964-87) (1988-89) p 
Total diagnosed 60 10 
Diagnosed per annum 2. 3 5 <0.006 
Age at diagnosis 29 21 <0.01 
(years, median) 
Without symptoms 31 (52%) 9 (90%) <0.001 
Cancer at diagnosis 8 (13%) 0 n.s. 
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Table IV: outcome in 70 patients with familial adenomatous polyposis. 
a) Refused surgery 
died, large bowel cancer 
lost after 0.5 yrs (age 39) & 24 yrs (age 78) 
b) Total colectomy and ileo-rectal anastomosis 
Cancer at colectomy 
died, large bowel cancer 
lost after 10 yrs (age 50) 
No cancer at colectomy 
died, duodenal cancer 
died, ischaemic heart disease 
died, desmoid perforation 
died, unknown cause 
lost after 1 yr (age 41), 2 yrs (age 19) 
& 23 yrs (age 56) 
well 
Histology of colectomy specimen not reviewed 
died, rectal cancer after 12 years 
lost after 10 yrs (age 35), 11 yrs (age 35), 
12 yrs (age 30) & 21 yrs (age 42) 
well 
c) Other operations 
died, large bowel cancer 
died, unknown cause 
well 
1 
2 
1 
1 
1 
1 
1 
2 
3 
42 
1 
4 
1 
3 
3 
3 
3 
58 
2 
50 
6 
9 
12 
8 
4 
0 
Figure I: Number · of patients 
diagnosed per year 
Number 
12 
7 
5 5 
4 4 
3 33 3 
2 2 2 
1 1 1 1 1 1 1 
1111111111 L 
" 
I I I I 
' 50 55 60 65 70 75 80 85 90 
Year 
20 
21 
Figure II: Age at diagnosis 
Number of Patients 
15 20 25 30 35 40 45 50 55 60 65 
Age at Diagnosis (years) 
Cancer ~ Symptoms 
PAl No symptoms/unknown 
Figure Ill: Race and Sex 
distribution 
White women 
24 
"Mixed race" women 
11 
Blacks = O 
White men 
28 
"Mixed race" men 
7 
22 
Figure IV: Number of affected 
members in each family 
Family history unknown - 2 
No family history - 7 
Smit 35 
Gerbach 2 
Maasdorp 6 
Lanzer 4 
Von Walt 3 
Smith 3 
Sylvester 4 
Osborne 4 
23 
24 
Figure v: Operations performed on all patients. 
Numbers indicate patients who underwent each operation. Numbers in 
parenthesis indicate total operations, where a patient had more than one 
operation of the same type. 
70 
patients 
No 
operati 
3 
67 
on 
2 
57 
2 
2 
1 
1 
2 
Colostomy 2 
1 
Total colectomy 
and ileo-rectal 
anastomosis 58 
2 
Pouch 4 
Proctocolectomy 2 
Colectomy 1 
Laparotomy 1 
(carcinomatosis) 
Proctectomy 2 
Gastrectomy 1 
Laparotomy for 
small bowel 
obstruction 5(6) 
Rectal excision 2 
Laparotomy for 
desmoid 3(7) 
Local excision 
Villous adenoma 1 
Revision ileo-
rectal 
anastomosis 1 
Pouch excision 2 
Rectal excision 1 
Colectomy 2 
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Figure VI: Survival if large bowel 
cancer present at diagnosis 
100% 
75% 
50% 
------- ------ . 
25% 
n • 8 
0 1 2 3 4 5 6 7 8 9 10 
Years f ram diagnosis 
100% 
75% 
50% 
25% 
0% 
Figure VII: The incidence of cancer of 
the rectal remnant after ilea-rectal 
anastomosis (with 95°/o confidence limits) 
82°/o 
0 5 10 15 20 
Years 
Total 58 38 30 17 15 4 
Cancer o 0 0 1 1 1 
26 
27 
Figure VIII: Duration of follow up 
of all patients. 
80 
70 
60 
50 
40 
30 
20 
10 
0 
Number of patients 
Mean • 11 years 
Median • 4 years 
0 2 4 6 8 10 12 14 16 18 20 22 24 
Years from diagnosis 
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Discussion 
Families affected 
. Although familial adenomatous polyposis has been reported in South African 
blacks58,59 none have been diagnosed at our hospital. One reason may be the 
founder effect causing a high incidence in white immigrants, as the first affected 
individual in one of our families arrived from Holland about 1685. 60 Another 
reason is that until recently the hospital has served a population of predominantly 
mixed or Caucasian descent. 
Implications of a Registry 
That familial adenomatous polyposis should be treated before symptoms appear if 
large bowel cancer is to be prevented is shown by the significantly higher incidence 
of cancer in our patients with symptoms at diagnosis (23 % with symptoms vs 3 % 
without). Cases identified through the screening programme were younger, while 
almost all were asymptomatic and none had cancer in comparison with a cancer 
incidence of 13 % in cases diagnosed earlier in the study (Table III). These data 
suggest that if a Polyposis Registry ensured efficient screening its cost might be 
justified by a reduction in large bowel cancer when familial adenomatous polyposis 
was diagnosed. However, calculating the likely cost of establishing and running a 
registry is beyond the scope of this study, as is the calculation of cost-saving which 
might flow from its operation. While the increase in detection of asymptomatic 
individuals and the decrease in the incidence of cancer at diagnosis is to be expected 
with the introduction of systematic screening, this has not previously been shown as 
there is no literature comparing patients diagnosed prior to and after the introduction 
of systematic screening. The success of family-based registry assisted surveillance 
could previously be inferred by the decrease in aggregate incidence of colorectal 
cancer in called up cases. 61 The longer a registry was been existence the lower the 
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incidence of cancer at diagnosis within that registry as fewer and fewer patients are 
probands and more and more are called up asymptomatic patients. 
Current role of a Registry 
The Registry has two main tasks , firstly, detection of asymptomatic carriers of the 
familial adenomatous polyposis gene and secondly the follow-up of patients who 
have a retained rectum. 
Management of a family starts with the identification of a patient with more than 
100 adenomatous polyps2. A complete family history is obtained and a family tree 
drawn up. The at-risk sibl ings, parents and offspring are identified. A number of 
questions in management however ari se: 
The St Mark's Registry initiates screening by sigmoidoscopy at 14 years2 as the 
procedure may be less frightening at this age. 23 Some American and European 
centers however begin screening at 10 years in order not to miss the occasional 
early malignancy.3 ,62 
Bussey recommends screening should be at intervals of 2 to 3 years by 
sigmoidoscopy alone2 and this recommended by both the Danish and Dutch 
Registries. 3 ,5 This may however not be adequate as colon cancer has been 
reported in the absence of rectal polyps63-66. 
The age at which screening should be discontinued is difficult to determine. The 
risk of development of polyposis decreases rapidly with increasing age. 2 The 
Danish Registry recommends surveillance until age 40 in the usual patient but 
increased to age 45 or 50 in those families that have a history of late development of 
polyps. 3 A study of data from St Mark's and the Western Australia Registries67 
allowed calculation of the cumulative risk of developing adenomas with increasing 
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age. The presence or absence of CHRPE and linked markers can be added to this 
age specific risk. 23 
Once the disease is detected in asymptomatic individuals, the only method of 
prevention of large bowel cancer is prophylactic proctocolectomy. This would 
result in a permanent ileostomy which is unacceptable to young, well, asymptomatic 
patients necessitating either reconstruction with an ileal pouch or retention of the 
rectum and ileorectal anastomosis. This latter option is a simpler procedure than the 
former and can be performed by any general surgeon. It does however leave 
residual rectal mucosa with the possibility of later malignant change. The registry 
thus must ensure adequate follow up of patients who have a retained rectum by 
outpatient sigmoidoscopy at six to 12 monthly intervals.68,69 
New developments in screening 
Rigid sigmoidoscopic surveillance requires that all offspring of an affected family 
member require examination every second year from age 10 to 14 to at least 40 
years old. Half will never manifest the disease but will be screened on at least 13 
occasions over 26 years. At each screening session, there is a high level of patient 
anxiety as to the result of the screening test. Compliance over this period of time is 
difficult to ensure and repeated examinations become expensive. 
Examination of the optic fundi for congenital hypertrophy of the retinal pigment 
epithelium (CHRPE) was first reported quite recently. 70 Chapman 71 found that 
between 2 and 40 areas of CHRPE occurred in all 40 gene carries studied while 
none of 35 controls had more than 2 areas. It appears that the lesions are present at 
birth and there may be complete consistency within families. 72 The presence of 
CHRPE thus strongly suggests that the individual carries the familial adenomatous 
polyposis gene. This ophthalmological examination requires only the mild 
inconvenience of pupillary dilatation during examination by an ophthalmologist. It 
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remains to be seen whether it is safe to not follow up family members who do not 
have CHRPE of families where affected members have CHRPE. 
Another recent addition to the armamentarium of the Registry is use of linked DNA 
markers which are becoming progressively more numerous. Recently markers have 
been found closer and closer to the familial adenomatous polyposis gene 73 since it 
was first shown to be located on the long arm of chromosome 5.74 The recent 
discovery of a marker lying within rather than near the gene 75, 76 should make 
other forms of screening obsolete. Screening for this gene at birth by a single blood 
test will eliminate the need for followup of unaffected family members. This 
should improve the acceptability of screening, as only those shown to carry the gene 
will ever need sigmoidoscopy, ideally performed in their early teens to identify the 
minority with large polyps in whom early colectomy should be considered. The 
remaining gene carriers will be able to choose a socially convenient time for their 
colectomy, usually in their late teens. This holds out the possibility of reducing the 
present biennial sigmoidoscopic examinations recommended2,3,5 in all at-risk 
individuals to one in the early teens and another immediately before colectomy, 
only in gene carriers. This will greatly reduce the work load and running costs of a 
Registry as well as the work of surgeons caring for affected families while the role 
of the clinical and molecular geneticist will expand considerably. The essential 
work of a Registry will involve ensuring perinatal testing of offspring of affected 
family members, the later sigmoidoscopic examinations of gene carriers, their 
eventual surgery and life-long postoperative follow-up. The relatively short 
professional lifespan of individual doctors makes it almost impossible for them to 
ensure this personally, particularly now that perinatal diagnosis is a real possibility, 
so the role of registries will become even more important. 
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As it is possible to identify the gene from a blood sample immediately after birth, it 
should soon be possible to identify the gene by amniocentesis in early pregnancy. 
The difficult ethical issue of therapeutic abortion will need to be addressed. 
Outcome 
While 58 patients underwent colectomy and ileo-rectal anastomosis, only four (6%) 
had an ileo-anal pouch formed. The increased short-term morbidity associated with 
the latter operation is not surprising. However the poor functional results (2/4 
permanent stomas) are at variance with the outcome reported after ileo-anal pouch 
operations elsewhere 77-79 . Our two patients who preferred a stoma had undergone 
the ileo-anal operation because they appeared unlikely to allow regular follow-up 
examinations. In retrospect both were probably temperamentally unsuited to the 
procedure. The ileo-anal pouch is considered to be the operation of choice to 
prevent large bowel cancer by a minority of surgeons. Most favour colectomy and 
ileo-rectal anastomosis 78, 79. The major objection to ileo-rectal anastomosis is the 
risk of cancer in the retained rectum, which rises steadily with time and appears to 
reach 8-32 % 80-83 at 20 years after the operation. 
However, after 20 years only one of 15 patients (7%) in this study developed rectal 
cancer. This would not justify a change from colectomy and ileo-rectal anastomosis 
as the standard procedure. It is also relevant that rectal polyps usually regress soon 
after colectomy and ileo-rectal anastomosis84 and this may partly explain why rectal 
cancer was so uncommon in our patients despite erratic follow-up. 
Foregut Lesions 
Foregut cancer is likely to become a major cause of death in patients who have 
undergone surgery to prevent colorectal cancer85. However, only one of our 
patients died of duodenal cancer. This was diagnosed by duodenoscopy in the 
presence of liver metastases and had been missed with an end-viewing instrument 
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six months previously. Furthermore, the apparent absence of duodenal adenomas in 
our patients illustrates that an end-viewing instrument is probably inadequate for 
examination of the foregut in familial adenomatous polyposis. A study of 102 cases 
using a side-viewing duodenoscope to take systematic biopsies and photographs 
identified duodenal adenomas in 94/102 (94 % ) and gastric adenomas in 6/73 
(8%)86. However, patients with confluent foregut adenomas or severe dysplasia 
present a difficult management problem. A prophylactic pancreaticoduodenectomy 
carries excessive morbidity while endoscopic destruction of adenomas is unlikely to 
prove adequate. 
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Conclusions 
Systematic screening increases the proportion of patients who are asymptomatic and 
decreases the mean age at the time of diagnosis. It should therefore reduce the 
frequency of large bowel cancer. 
Total colectomy and ileo-rectal anastomosis has proved to be a safe prophylactic 
operation in the short-term , with a low long-term incidence of rectal cancer. 
Because of the limited number of ileo-anal pouch operations performed, data are too 
sparse to allow firm conclusions. This is particularly so because these operations 
were performed early in the local experience. Others have found an increase in the 
short-term morbidity, but the long-term function appears to be similar to that 
following total colectomy and ileo-rectal anastomosis. 
Calculations of the likely costs and benefits of a registry are probably worth 
pursuing. 
New developments m genetic techniques will allow identification of at-risk 
individuals at birth thus reducing the need for sigmoidoscopic screening and 
improving patient compliance. A Registry will be essential in ensuring that at-risk 
infants are screened and that if the gene is present they are optimally followed up. 
When prenatal diagnosis by amniocentesis becomes a reality, the difficult ethical 
issue of therapeutic abortion will need to be addressed. 
Appendix 
AUDIT OF GSH FAMTUAL ADENOMATOUS POLYPOSTS EXPERIBNCE 
FAPFORM.DOC 
SURNAME 
FIRSTNAME 
HOSPNO 
FAMILY OF ORIGIN 
DOB / MAIDEN NAME 
mo/day/yr 
R/S 1 2 3 4 5 6 7 8 
Always code "unknown" as 9 
GENERA TTON I II III IV V VI 
SIB NO 1 2 3 4 5 6 7 8 9 IO 11 12 CODER: DATE: I I 
PRESENTATION 1 propositus 2 called up, asymptomatic 
3 called up, symptomatic 4 presented, asymptomatic 
FIRST SEEN DATE 
FIRST DIAG DATE 
LAST SIG RESULT 
mo/day/yr 
I 
FffiST SIG DATE 
LAST SIG DATE 
l polyp(s) 2 ca 3 normal 
9 unknown ANAST HT ON RIGID SIG (cm): 
LAST KNOWN ALIVE DATE 
OPl DATE l ileorectal 2 panproctocolectomy 
3 pouch 4 subtot colect 5 other 9 unknown 0 no op 
OPlST A Y days OPl COMP l died 2 anasleak 3 wnd inf 
4 SB obst 5 abdom abs 6 bleed 7 other 9 no inf O nil 
OP2 DATE l ileorectal 2 panproctocolect 
3 pouch 4 subtot colect 5 other 9 unknown 0 no op 
OP2ST A Y days OP2 COMP 1 died 2 anasleak 3 wnd inf 
4 SB obst 5 abdom abs 6 bleed 7 other 9 no inf O nil 
OP3 DATE 1 ileorectal 2 panproctocolect 
3 pouch 4 subtot colect 5 other 9 unknown 0 no op 
OP3STAY days OP3 COMP 
4 SB obst 5 abdom abs 
OP COMMENT 
1 died 2 anasleak 3 wnd inf 
6 bleed 7 other 9 no inf O nil 
TOTAL OPS FOR FAP: 
(excl fulguration) 
35 
HISTO 1 adnmtous polyps 2 Ca "A " 3 Ca "B " 4 Ca "C" 
5 Ca "D " 8 no polyps 9 no info PATH NO: 
GARDNER'S SYN 
COMMENT 
1 yes 2 no 8 uncertain 
F-UPBY 1 GSH 2 MSE 3 WHR 5 other pvt 
6 other hosp 9 no in fo 0 lost 
9 no info 
SIG AT LEAST YRL Y POSTOPl yes 2 no 3 no info 
F-UP 
STATUS 
1 A,W,f-up OK 2 A,W,not f-up 3 D,ca colon 
4 A +ca colon 7 lost 8 D of other cause 
DATE CA DIAGNOSED 
FAP DIAGNOSIS 
GASTROSCOPY 
3 both types polyp 
DATE DIED 
I proven 2 > 40 , no polyps 
1 adnmtous polyp 2 other polyp 
4 no polyp 5 other 8 not scoped 
GENERAL COMMENTS 
ON COMPUTER y N 
3 uncertain 
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